Eziclen Drug Utilisation in Real Life Setting

NCT02630680 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1286

Last updated 2019-01-07

No results posted yet for this study

Summary

The purpose of the study is to assess Eziclen/Izinova drug utilisation in the real life setting in a representative sample of the European target population.

Conditions

  • Bowel Cleansing

Interventions

DRUG

Eziclen®/Izinova®

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-04-25
Completion
2017-04-25

Countries

  • Czechia
  • Germany
  • Netherlands
  • Poland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02630680 on ClinicalTrials.gov